Flagship explainer
How Sarepta Therapeutics, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $1.9B | 100% |
| |
| Cost of revenue | $25.5M | 1% |
|
| $1.8B | 99% |
| |
| −$700M | −38% |
| |
| Income before tax | −$702M | −38% |
|
| Income tax | $11.2M | 1% |
|
| −$713M | −38% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-084144